BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

152 related articles for article (PubMed ID: 33085752)

  • 1. Treatment strategies in ischaemic left ventricular dysfunction: a network meta-analysis.
    Gaudino M; Hameed I; Khan FM; Tam DY; Rahouma M; Yongle R; Naik A; Di Franco A; Demetres M; Petrie MC; Jolicoeur EM; Girardi LN; Fremes SE
    Eur J Cardiothorac Surg; 2020 Oct; ():. PubMed ID: 33085752
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Percutaneous coronary intervention versus coronary bypass surgery for unprotected left main disease: a meta-analysis of randomized controlled trials.
    Rahouma M; Abouarab A; Di Franco A; Leonard JR; Lau C; Kamel M; Ohmes LB; Girardi LN; Gaudino M
    Ann Cardiothorac Surg; 2018 Jul; 7(4):454-462. PubMed ID: 30094209
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Revascularization strategies versus optimal medical therapy in chronic coronary syndrome: A network meta-analysis.
    Galli M; Benenati S; Zito A; Capodanno D; Zoccai GB; Ortega-Paz L; Iaconelli A; D'Amario D; Porto I; Burzotta F; Trani C; De Caterina R; Gaudino M; Escaned J; Angiolillo DJ; Crea F
    Int J Cardiol; 2023 Jan; 370():58-64. PubMed ID: 36265647
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Mortality after drug-eluting stents vs. coronary artery bypass grafting for left main coronary artery disease: a meta-analysis of randomized controlled trials.
    Ahmad Y; Howard JP; Arnold AD; Cook CM; Prasad M; Ali ZA; Parikh MA; Kosmidou I; Francis DP; Moses JW; Leon MB; Kirtane AJ; Stone GW; Karmpaliotis D
    Eur Heart J; 2020 Sep; 41(34):3228-3235. PubMed ID: 32118272
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Percutaneous coronary intervention versus coronary artery bypass graft for left main coronary artery disease: A meta-analysis.
    Gallo M; Blitzer D; Laforgia PL; Doulamis IP; Perrin N; Bortolussi G; Guariento A; Putzu A
    J Thorac Cardiovasc Surg; 2022 Jan; 163(1):94-105.e15. PubMed ID: 32499076
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Comparison on the long-term outcomes post percutaneous coronary intervention or coronary artery bypass grafting for bifurcation lesions in unprotected left main coronary artery].
    Yang BG; Yu XP; Chen F; Lyu SZ; Li Q; He JQ; Yuan F
    Zhonghua Xin Xue Guan Bing Za Zhi; 2017 Jan; 45(1):19-25. PubMed ID: 28100341
    [No Abstract]   [Full Text] [Related]  

  • 7. Is the world ready for the STICH 3.0 trial?
    Vervoort D; Jolicoeur ME; Marquis-Gravel G; Fremes SE
    Curr Opin Cardiol; 2022 Nov; 37(6):474-480. PubMed ID: 36094455
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Efficacy comparison of 3 strategies for real-world stable coronary artery disease patients with three-vessel disease].
    Liu R; Jiang L; Xu LJ; Tian J; Zhao XY; Zhang Y; Xu JJ; Song Y; Wang HH; Gao Z; Song L; Yuan JQ
    Zhonghua Xin Xue Guan Bing Za Zhi; 2017 Dec; 45(12):1049-1057. PubMed ID: 29325365
    [No Abstract]   [Full Text] [Related]  

  • 9. Revascularization in Patients With Multivessel Coronary Artery Disease and Severe Left Ventricular Systolic Dysfunction: Everolimus-Eluting Stents Versus Coronary Artery Bypass Graft Surgery.
    Bangalore S; Guo Y; Samadashvili Z; Blecker S; Hannan EL
    Circulation; 2016 May; 133(22):2132-40. PubMed ID: 27151532
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Effects of Percutaneous Coronary Intervention and Coronary Artery Bypass Grafting on Clinical Outcomes in Patients with Reduced Ejection Fraction Heart Failure and Coronary Heart Disease: A Meta-Analysis.
    Yu ZX; Yan J; Wang MY; Chen R; Luo JY; Li XM; Xie X; Ma YT
    Heart Surg Forum; 2023 Feb; 26(1):E062-E073. PubMed ID: 36856505
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Meta-analysis of three randomized controlled trials comparing coronary artery bypass grafting with percutaneous coronary intervention using drug-eluting stenting in patients with diabetes.
    Fanari Z; Weiss SA; Zhang W; Sonnad SS; Weintraub WS
    Interact Cardiovasc Thorac Surg; 2014 Dec; 19(6):1002-7. PubMed ID: 25185569
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Percutaneous Coronary Intervention vs Coronary Artery Bypass Grafting in Patients With Left Main Coronary Artery Stenosis: A Systematic Review and Meta-analysis.
    Giacoppo D; Colleran R; Cassese S; Frangieh AH; Wiebe J; Joner M; Schunkert H; Kastrati A; Byrne RA
    JAMA Cardiol; 2017 Oct; 2(10):1079-1088. PubMed ID: 28903139
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Percutaneous Coronary Intervention Using Drug-Eluting Stents Versus Coronary Artery Bypass Grafting for Unprotected Left Main Coronary Artery Stenosis: A Meta-Analysis of Randomized Trials.
    Nerlekar N; Ha FJ; Verma KP; Bennett MR; Cameron JD; Meredith IT; Brown AJ
    Circ Cardiovasc Interv; 2016 Dec; 9(12):. PubMed ID: 27899408
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Percutaneous coronary intervention with drug-eluting stents versus coronary artery bypass grafting in left main coronary artery disease: an individual patient data meta-analysis.
    Sabatine MS; Bergmark BA; Murphy SA; O'Gara PT; Smith PK; Serruys PW; Kappetein AP; Park SJ; Park DW; Christiansen EH; Holm NR; Nielsen PH; Stone GW; Sabik JF; Braunwald E
    Lancet; 2021 Dec; 398(10318):2247-2257. PubMed ID: 34793745
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Long-term outcomes of percutaneous versus surgical revascularization in patients with diabetes and left main coronary artery disease: A meta-analysis of randomized controlled trials.
    Carvalho PEP; Veiga TMA; Machado FSL; Porto GV; Pirez J; Rivera M; Melo PC; Braghiroli J; Cardoso R
    J Card Surg; 2022 Dec; 37(12):4646-4653. PubMed ID: 36259716
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Meta-Analysis Comparing Percutaneous Coronary Revascularization Using Drug-Eluting Stent Versus Coronary Artery Bypass Grafting in Patients With Left Ventricular Systolic Dysfunction.
    Cui K; Zhang D; Lyu S; Song X; Yuan F; Xu F; Zhang M
    Am J Cardiol; 2018 Nov; 122(10):1670-1676. PubMed ID: 30220418
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Percutaneous coronary intervention vs. coronary artery bypass grafting for left main revascularization: an updated meta-analysis.
    Bajaj NS; Patel N; Kalra R; Marogil P; Bhardwaj A; Arora G; Arora P
    Eur Heart J Qual Care Clin Outcomes; 2017 Jul; 3(3):173-182. PubMed ID: 28838092
    [TBL] [Abstract][Full Text] [Related]  

  • 18. STICH3C: Rationale and Study Protocol.
    Fremes SE; Marquis-Gravel G; Gaudino MFL; Jolicoeur EM; Bédard S; Masterson Creber R; Ruel M; Vervoort D; Wijeysundera HC; Farkouh ME; Rouleau JL;
    Circ Cardiovasc Interv; 2023 Aug; 16(8):e012527. PubMed ID: 37582169
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Stroke Rates Following Surgical Versus Percutaneous Coronary Revascularization.
    Head SJ; Milojevic M; Daemen J; Ahn JM; Boersma E; Christiansen EH; Domanski MJ; Farkouh ME; Flather M; Fuster V; Hlatky MA; Holm NR; Hueb WA; Kamalesh M; Kim YH; Mäkikallio T; Mohr FW; Papageorgiou G; Park SJ; Rodriguez AE; Sabik JF; Stables RH; Stone GW; Serruys PW; Kappetein AP
    J Am Coll Cardiol; 2018 Jul; 72(4):386-398. PubMed ID: 30025574
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Coronary artery bypass graft surgery versus percutaneous coronary intervention with drug-eluting stents for left main coronary artery disease: A meta-analysis of randomized trials.
    Putzu A; Gallo M; Martino EA; Ferrari E; Pedrazzini G; Moccetti T; Cassina T
    Int J Cardiol; 2017 Aug; 241():142-148. PubMed ID: 28438354
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.